参考文献/References:
[1]Pundi KN,Johnson JN,Dearani JA,et al. 40-year follow-up after the Fontan operation:long-term outcomes of 1,052 patients[J].? Am Coll Cardiol,2015,66(15):1700-1710. [2]Jacobs JP,Mayer JE Jr,Mavroudis C,et al. The society of thoracic surgeons congenital heart surgery database:2017 update on outcomes and quality[J]. Ann Thorac Surg,2017,103(3):699-709.[3]Schilling C,Dalziel K,Nunn R,et al. The Fontan epidemic:population projections from the Australia and New Zealand Fontan Registry[J]. Int J Cardiol,2016,219:14-19. [4]Griffiths ER,Lambert LM,Ou Z,et al. Fontan-associated liver disease after heart transplant[J].?ediatr Transplant,2023,27(2):e14435.[5]Alsaied T,Rathod RH,Aboulhosn JA,et al. Reaching consensus for unified medical language in Fontan care[J]. ESC Heart Fail,2021,8(5):3894-3905.[6]Caruthers RL,Kempa M,Loo A,et al. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis[J]. Pediatr Cardiol,2013,34(2):256-261.[7]Schumacher KR,Stringer KA,Donohue JE,et al. Fontan-associated protein-losing enteropathy and plastic bronchitis[J]. J Pediatr,2015,166(4):970-977.[8]Dori Y,Keller MS,Rome JJ,et al. Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease[J]. Circulation,2016,133(12):1160-1170.[9]Schumacher KR,Singh TP,Kuebler J,et al. Risk factors and outcome of Fontan-associated plastic bronchitis:a case-control study[J]. J Am Heart Assoc, 2014,3(2):e000865.[10]Sharma VJ,Iyengar AJ,Zannino D,et al. Protein-losing enteropathy and plastic bronchitis after the Fontan procedure[J].? Thorac Cardiovasc Surg,2021,161(6):2158-2165.e4.[11]Mertens L,Hagler DJ,Sauer U,et al. Protein-losing enteropathy after the Fontan operation:an international multicenter study[J]. J Thorac Cardiovasc Surg,1998,115(5):1063-1073.[12]Feldt RH,Driscoll DJ,Offord KP,et al. Protein-losing enteropathy after the Fontan operation[J]. J Thorac Cardiovasc Surg,1996,112(3):672-680.[13]Schleiger A,Ovroutski S,Peters B,et al. Treatment strategies for proteinlosing enteropathy in Fontan-palliated patients[J]. Cardiol Young,2020,30(5):698-709.[14]John AS,Johnson JA,Khan M,et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation[J]. J Am Coll Cardiol,2014,64(1):54-62.[15]Racz J,Mane G,Ford M,et al. Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway casts[J]. Ann Am Thorac Soc,2013,10(2):98-107.[16]Vyas H,Driscoll DJ,Cabalka AK,et al. Results of transcatheter Fontan fenestration to treat protein losing enteropathy[J]. Catheter Cardiovasc Interv,2007,69(4):584-589. [17]Rychik J,Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy[J]. Am J Cardiol,2002,90(6):672-674.[18]Ostrow AM,Freeze H,Rychik J. Protein-losing enteropathy after Fontan operation:investigations into possible pathophysiologic mechanisms[J]. Ann Thorac Surg,2006,82(2):695-700.[19]Lencer WI. Patching a leaky intestine[J]. N Engl J Med,2008,359(5):526-528.[20]Ntiamoah P,Mukhopadhyay S,Ghosh S,et al. Recycling plastic:diagnosis and management of plastic bronchitis among adults[J]. Eur Respir Rev,2021,30(161):210096. [21]Smith CL,Liu M,Saravanan M,et al. Liver lymphatic anatomy and role in systemic lymphatic disease[J]. Eur Radiol,2022,32(1):112-121.[22]Daniels CJ,Bradley EA,Landzberg MJ,et al. Fontan-associated liver disease:proceedings from the American College of Cardiology Stakeholders Meeting,October 1 to 2,2015,?ashington DC[J].? Am Coll Cardiol,2017,70(25):3173-3194.[23]Heath L,Ling S,Racz J,et al. Prospective,longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator[J]. Pediatr Cardiol,2011,32(8):1182-1189.[24]Rubin BK. Plastic bronchitis[J]. Clin Chest Med,2016,37(3):405-408.[25]Eason DE,Cox K,Moskowitz WB. Aerosolised heparin in the treatment of Fontan-related plastic bronchitis[J]. Cardiol Young,2014,24(1):140-142.[26]Pa?ga-Bysiecka I,Polewczyk AM,Polewczyk M,et al. Plastic bronchitis-a serious rare complication affecting children only after Fontan procedure?[J].? Clin Med,2021,11(1):44.[27]Lis G,Cichocka-Jarosz E,Jedynak-Wasowicz U,et al. Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure[J].? Bras Pneumol,2014,40(1):82-85.[28]Okano S,Sugimoto M,Takase M,et al. Effectiveness of high-dose spironolactone therapy in a patient with recurrent protein-losing enteropathy after the Fontan procedure[J]. Intern Med,2016,55(12):1611-1614.[29]Uzun O,Wong JK,Bhole V,et al. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan[J]. Ann Thorac Surg,2006,82(6):e39-40.[30]Goldberg DJ,Zak V,Goldstein BH,et al. Results of the FUEL trial[J]. Circulation,2020,141(8):641-651.[31]Shah A,Donovan J,Marino P,et al. A lesson in plasticity:a 74-year-old man with plastic bronchitis[J].?horax,2017,72(11):1055-1057.[32]Moua T,Olson EJ,Jean HC,et al. Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy[J]. Am J Respir Crit Care Med,2012,186(4):389-390.[33]Itkin MG,McCormack FX,Dori Y. Diagnosis and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and percutaneous embolization[J]. Ann Am Thorac Soc,2016,13(10):1689-1696.[34]Salman S,Shah A,Drinkwater DC,et al. Plastic bronchitis:is thoracic duct ligation a real surgical option?[J]. Ann Thorac Surg,2006,81(6):2281-2283.[35]Kelly B,Mohanakumar S,Hjortdal VE. Diagnosis and management of lymphatic disorders in congenital heart disease[J]. Curr Cardiol Rep,2020,22(12):164.[36]Cedars A,Kutty S,Danford D,et al. Systemic ventricular assist device support in Fontan patients:A report by ACTION[J].? Heart Lung Transplant,2021,40(5):368-376.